Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Condition:   LymphangioleiomyomatosisInterventions:   Drug: albuterol inhaler;   Procedure: PFT;   Drug: albuterol nebulizerSponsor:   National Heart, Lung, and Blood Institute (NHLBI)Recruiting - verified October 2014

Source: ClinicalTrials.gov - February 23, 2013 Category: Research Source Type: clinical trials